Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole
出版年份 2012 全文链接
标题
Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 56, Issue 11, Pages 5898-5906
出版商
American Society for Microbiology
发表日期
2012-09-05
DOI
10.1128/aac.01115-12
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine
- (2012) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility
- (2012) Shawn R. Lockhart et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Extensive Genetic Diversity within the Dutch Clinical Cryptococcus neoformans Population
- (2012) Ferry Hagen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Correlation of antifungal susceptibility and molecular type within theCryptococcus neoformans/C. gattiispecies complex
- (2012) Luciana Trilles et al. MEDICAL MYCOLOGY
- Resistance of Asian Cryptococcus neoformans Serotype A Is Confined to Few Microsatellite Genotypes
- (2012) Weihua Pan et al. PLoS One
- Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates Obtained through Population-Based Surveillance in South Africa in 2002-2003 and 2007-2008
- (2011) Nelesh P. Govender et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of a Cryptococcus neoformans Cytochrome P450 Lanosterol 14α-Demethylase (Erg11) Residue Critical for Differential Susceptibility between Fluconazole/Voriconazole and Itraconazole/Posaconazole
- (2011) Edward Sionov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2011) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2011) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging Pathogen
- (2011) J. R. Harris et al. CLINICAL INFECTIOUS DISEASES
- Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method
- (2011) Michael A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India
- (2011) A. Chowdhary et al. JOURNAL OF MEDICAL MICROBIOLOGY
- A Diverse Population of Cryptococcus gattii Molecular Type VGIII in Southern Californian HIV/AIDS Patients
- (2011) Edmond J. Byrnes et al. PLoS Pathogens
- Heteroresistance of Cryptococcus gattii to Fluconazole
- (2010) A. Varma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii Isolates
- (2010) F. Hagen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
- (2010) John R. Perfect et al. CLINICAL INFECTIOUS DISEASES
- Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
- (2010) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2010) A. Espinel-Ingroff et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In Vitro Susceptibility of the Yeast Pathogen Cryptococcus to Fluconazole and Other Azoles Varies with Molecular Genotype
- (2010) H. S. Chong et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mixed Infections and In Vivo Evolution in the Human Fungal Pathogen Cryptococcus neoformans
- (2010) M. Desnos-Ollivier et al. mBio
- Emergence and Pathogenicity of Highly Virulent Cryptococcus gattii Genotypes in the Northwest United States
- (2010) Edmond J. Byrnes et al. PLoS Pathogens
- Three-Dimensional Model of Lanosterol 14 -Demethylase from Cryptococcus neoformans: Active-Site Characterization and Insights into Azole Binding
- (2009) C. Sheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints
- (2009) A. Dalhoff et al. INFECTION
- Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Genotyping of MexicanCryptococcus neoformansandC. gattiiisolates by PCR-fingerprinting
- (2009) L. R. Castañón Olivares et al. MEDICAL MYCOLOGY
- Diversidad del complejo de especies Cryptococcus neoformans-Cryptococcus gattii
- (2009) Marjan Bovers et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Mecanismos de resistencia a los antifúngicos: levaduras y hongos filamentosos
- (2009) Ana Espinel-Ingroff REVISTA IBEROAMERICANA DE MICOLOGIA
- Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
- (2008) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba
- (2008) M.-T. Illnait-Zaragozi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus
- (2008) J. L. Rodriguez-Tudela et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro susceptibility of Cryptococcus gattii clinical isolates
- (2008) A. Gomez-Lopez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
- (2008) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search